Rapid detection of methicillin-sensitive and resistanct Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci from blood cultures by automated PCR assay
© Hirvonen and Kaukoranta; licensee BioMed Central Ltd. 2011
Published: 29 June 2011
Introduction / objectives
We assessed the usefulness of a new automated molecular assay (GenomEraTM MRSA Confirm, Abacus Diagnostica Oy, Finland), which amplifies simultaneously the marker of methicillin resistance (mecA) and a Staphylococcus aureus-specific DNA segment, in detection of methicillin sensitive and resistant S. aureus (MSSA and MRSA) and other methicillin resistant staphylococci (MRCoNS) in blood culture samples.
We studied a total of 102 blood cultures (including 92 positive and 10 negative cultures) and two MRSA-positive control samples. All samples were inoculated into BacT/Alert enrichment bottles (bioMérieux, France) and analysed by routine diagnostic and antimicrobial susceptibility methods as well as GenomEra MRSA Confirm assay after a growth-positive signal or after a 7 days of incubation. The thermal cycling and detection were performed in GenomEra CDX instrument directly from diluted blood culture bottle medium without previous DNA extraction step. Results were obtained within an hour.
A total of 41 S. aureus (39 MSSA and 2 MRSA) and 27 MRCoNS strains were identified from the blood cultures and control samples byroutine methods. Of these, all except one were correctly identified by the GenomEra assay. The deviant result was obtained from a multi-bacterial sample, containing MRCoNS and methicillin susceptible staphylococcus other than S. aureus in a ratio of <1:1 000. Thus the overall sensitivity of the assay method was 98.5 %. For MRSA and MSSA, the sensitivity was 100 %. No false positive results were obtained with the assay, yielding a specificity of 100 %.
GenomEra assay is a useful method for direct detection of MRSA, MSSA and MRCoNS in blood cultures. It offers a rapid support to infection control and clinical decision making.
Disclosure of interest
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.